Original Research

Vaccine Hesitancy: Prevalence and Strategies to Improve Uptake of Optional Vaccines Among Immunocompromised Patients and Health Care Providers

DOI https://doi.org/10.70302/jpsim.v6i4.2564
Received: 30 Jan 2025 Revised: 22 Mar 2025 Accepted: 11 Oct 2025 Published Online: 21 Nov 2025

Abstract

Objective

This study was carried out for determination of vaccine hesitancy and its logics among health care providers (HCPs) across Punjab and immunocompromised patients.

Methods

A cross-sectional analytical study was carried out and collected data from 169 HCPs across Punjab and 199 immunocompromised patients from healthcare facilities associated with Gujranwala Medical College and Al-Aleem Medical College using consecutive snowball sampling method. A self-administered, valid survey form was used to obtain quantitative data. Vaccine hesitancy was defined as refusal to register or uptake an advised vaccine shot despite availability of vaccination services.

Results

In our study sample (n=368), mean age of participants (n=368) was 35 years, and 41% participants were female. 199 participants (54.1%) were immunocompromised patients while 45.9% were HCPs. In our total study population, 151 (41.0%) were vaccine hesitant, among them 51% were HCPs. Only 129 (35.1%) participants have a positive perception & attitude towards general vaccination. The difference in prevalence of vaccine hesitancy is significant between HCPs and Immunocompromised patients (P <0.001). Analysis on Logistic regression showed male gender, younger age group, negative perception and attitude towards vaccination are significant predictors of vaccine hesitancy. Taken yearly influenza vaccine shot was found a non-significant predictor.

Conclusion

It is concluded that vaccine hesitancy is still high among immunocompromised patients and healthcare providers. Continuous health education and media campaigns need to target young male individuals who are under influence of social media.

Keywords
Vaccine Hesitancy Vaccine Immunization Vaccine confidence Optional vaccines immunocompromised patients.

How to Cite This Article

Dar UF, Maqsood M, Javed MT, Afzal M, Iqbal T, Rajput NR. Vaccine Hesitancy: Prevalence and Strategies to Improve Uptake of Optional Vaccines Among Immunocompromised Patients and Health Care Providers. J Pak Soc Intern Med. 2025;6(4):348–353. doi:10.70302/jpsim.v6i4.2564

⭳ Download PDF

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

References

  1. Bussink-Voorend D, Hautvast JL, Vandeberg L, Visser O, Hulscher ME. A systematic literature review to clarify the concept of vaccine hesitancy. Nat Human Behav. 2022;6(12):1634-48.
  2. Neely SR, Eldredge C, Ersing R, Remington C. Vaccine hesitancy and exposure to misinformation: a survey analysis. J General Intern Med. 2022:37(1):179-87.
  3. Soares P, Rocha JV, Moniz M, Gama A, Laires PA, Pedro AR, et al. Factors associated with COVID-19 vaccine hesitancy. Vaccines. 2021;9(3):300.
  4. Dubé È, Ward JK, Verger P, MacDonald NE. Vaccine hesitancy, acceptance, and anti-vaccination: trends and future prospects for public health. Annu Rev Public Health. 2021;42(1):175-91.
  5. Biswas MR, Alzubaidi MS, Shah U, Abd-Alrazaq AA, Shah Z. A scoping review to find out worldwide COVID-19 vaccine hesitancy and its underlying determinants. Vaccines. 2021;9(11):1243.
  6. Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eu J Epidemiol. 2020;35(8):775-9.
  7. Adel ZS, Hasan A, Ahmed E, Alterafi H, AlSammak S, Jawad JS. Prevalence of vaccine hesitancy towards childhood vaccination program among guardians attending primary health care in Bahrain. Saudi J Nurs Health Care. 2019;2(9):284-9.
  8. Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D, et al. High Rates of COVID-19 Vaccine Hesitancy and Its Association with Conspiracy Beliefs: A Study in Jordan and Kuwait among Other Arab Countries. Vaccines. 2021;9(1):42.
  9. Siegler AJ, Luisi N, Hall EW, Bradley H, Sanchez T, Lopman BA. Trajectory of COVID-19 vaccine hesitancy over time and association of initial vaccine hesitancy with subsequent vaccination. JAMA Network Open. 2021;4(9):e2126882-e.
  10. Lahouati M, De Coucy A, Sarlangue J, Cazanave C. Spread of vaccine hesitancy in France: What about YouTube™? Vaccine. 2020;38(36):5779-82.
  11. Greenberg J, Dubé E, Driedger M. Vaccine hesitancy: in search of the risk communication comfort zone. PLoS Currents. 2017; doi: 10.1371/currents.outbreaks.0561a011117a1d1f9596e24949e8690b. doi:10.1371/currents.outbreaks.0561a011117a1d1f9596e24949e8690b
  12. Marshall GS. Vaccine hesitancy, history, and human nature: the 2018 Stanley A. Plotkin Lecture. Oxford University Press US; 2019. p. 1-8.
  13. Jarrett C, Wilson R, O'Leary M, Eckersberger E, Larson HJ. Strategies for addressing vaccine hesitancy - A systematic review. Vaccine. 2015;33(34): 4180-90.
  14. Larson HJ, Jarrett C, Schulz WS, Chaudhuri M, Zhou Y, Dube E, et al. Measuring vaccine hesitancy: the development of a survey tool. Vaccine. 2015;33(34):4165-75.
  15. Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014;32(19):2150-9.
  16. Paterson P, Meurice F, Stanberry LR, Glismann S, Rosenthal SL, Larson HJ. Vaccine hesitancy and healthcare providers. Vaccine. 2016;34(52):6700-6.
  17. Al-Mohaithef M, Padhi BK. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: a web-based national survey. J Multidisciplin Healthcare. 2020;13:1657-63.
  18. Fridman A, Gershon R, Gneezy A. COVID-19 and vaccine hesitancy: A longitudinal study. PloS one. 2021;16(4):e0250123.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. © 2025 Journal of Pakistan Society of Internal Medicine.